recombinant viral vector AAV5-RBD-S vaccine(Biocad)

N/A

Report date: 2023/01/31 20:00:21

Base Information

Drug Namerecombinant viral vector AAV5-RBD-S vaccine(Biocad)
Drug Alias NameBCD-250
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBIOCAD JSC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBIOCAD JSC
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A